Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alvotech (ALVO)

Alvotech (ALVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alvotech 9 RUE DE BITBOURG LUXEMBOURG N4 L-1273 LUX

www.alvotech.com Employees: 1,032 P: 354-422-4500

Sector:

Medical

Description:

Alvotech Holdings S.A. is a biotech company. It focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech Holdings S.A., formerly known as Oaktree Acquisition Corp. II, is based in REYKJAVIK, Iceland.

Key Statistics

Overview:

Market Capitalization, $K 1,495,351
Enterprise Value, $K 2,512,501
Shares Outstanding, K 301,482
Float, K 300,095
% Float 99.54%
Short Interest, K 2,057
Short Float 0.68%
Days to Cover 3.36
Short Volume Ratio 0.52
% of Insider Shareholders 0.46%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 489,680 K
Annual Net Income, $ -231,860 K
Last Quarter Sales, $ 113,860 K
Last Quarter Net Income, $ -5,250 K
EBIT, $ 10,580 K
EBITDA, $ 100,940 K

Growth:

1-Year Return -62.28%
3-Year Return -57.29%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 11/12/25
Next Earnings Date 03/25/26
Earnings Per Share ttm 0.23
EPS Growth vs. Prev Qtr -114.29%
EPS Growth vs. Prev Year -110.53%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ALVO Ratios

Ratio
Price/Earnings ttm 21.39
Price/Earnings forward 10.05
Price/Earnings to Growth N/A
Return-on-Equity % -26.10%
Return-on-Assets % 5.28%
Profit Margin % -47.35%
Debt/Equity -6.36
Price/Sales 2.56
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.59
Interest Coverage -0.28
60-Month Beta 0.11
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar